Drug Type Recombinant protein |
Synonyms AIM, ApoA1 Milano, r-ApoA-I Milano + [5] |
Target |
Mechanism APOA1 stimulants(Apolipoprotein A-I stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Phase 2 | CA | 03 Dec 2015 | |
Atherosclerosis | Phase 2 | CZ | 03 Dec 2015 | |
Atherosclerosis | Phase 2 | HU | 03 Dec 2015 | |
Atherosclerosis | Phase 2 | NL | 03 Dec 2015 | |
Atherosclerosis | Phase 2 | PL | 03 Dec 2015 | |
Acute Coronary Syndrome | Phase 2 | US | - | |
Acute Coronary Syndrome | Phase 2 | CA | - | |
Acute Coronary Syndrome | Phase 2 | CZ | - | |
Acute Coronary Syndrome | Phase 2 | HU | - | |
Acute Coronary Syndrome | Phase 2 | NL | - |
Phase 1/2 | 122 | xxqzuprqtt(fcjqkfygkg) = qfvmfwwknl sskxsawejb (qlqcesyjtz ) View more | Negative | 01 Sep 2018 | |||
Placebo | xxqzuprqtt(fcjqkfygkg) = oelgffxxdx sskxsawejb (qlqcesyjtz ) View more | ||||||
Phase 1/2 | 126 | (MDCO-216) | ewtudzoqby(emfrczejte) = ugkbackpxr cifplowevi (qbbetkzpbo, cnzswozbic - lkvmmackxq) View more | - | 13 Jul 2017 | ||
Placebo (Placebo) | ewtudzoqby(emfrczejte) = ietzmpjnno cifplowevi (qbbetkzpbo, ixhjkeezmz - zyzhtrkudw) View more |